Blu Label Unlimited Group (BLU) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
27 Aug, 2026Opening remarks and agenda
The meeting was declared properly constituted with a quorum present and all board committee chairpersons and executives in attendance.
Notice of the meeting was given in accordance with the MOI and Companies Act, and minutes of the previous AGM were approved.
Voting was conducted electronically via Computershare, with a scrutineer nominated from the transfer secretaries.
Board and executive committee updates
Reelection of three directors was proposed: M.S. Levy, D.A. Suntup, and S.J. Vilakazi, all offering themselves for reelection.
Appointment of SNG Grant Thornton as auditors and Mr. A. Philippou as designated partner was recommended.
Election of audit committee members, including Ms. N.P. Nkasana, Ms. L.E. Mthimunye, Mr. J.S. Mthimunye (as chairman), and S.J. Vilakazi, was proposed.
Corporate governance
The board acknowledged progress in diversity, achieving over 60% Black representation and recent appointments of Black women, with ongoing efforts at management levels.
Leadership development and targeted recruitment are being used to improve diversity at junior and middle management levels.
Governance improvements at Cell C post-recapitalization included restructuring the board, appointing a new CEO and Exco, and establishing an oversight committee for related party transactions.
Cell C's board now possesses core telco skills, and performance improvements have been observed.
Latest events from Blu Label Unlimited Group
- Significant declines in earnings expected due to Cell C restructuring and listing impacts.BLU
Trading update - Normalized revenue ZAR 9.4bn, EBITDA ZAR 923m, core headline earnings ZAR 681m, dividend and buyback.BLU
H2 2026 - Earnings per share are expected to rise over 100%, but underlying earnings fell when excluding Cell C effects.BLU
Trading update - Earnings per share are expected to rise by over 20% for the year ended 31 May 2025.BLU
Trading update - Earnings per share to fall over 20%, impacted by Cell C restructuring and related losses.BLU
Trading update - Gross revenue up 16% to ZAR 89.3bn, but core HEPS down 34% amid challenging conditions.BLU
H2 2024 - Gross revenue up 8% to R47.4bn, margins improved, but EBITDA fell on higher finance costs.BLU
H1 2025 - Profit and margin growth accelerated, led by digital innovation and Cell C's operational turnaround.BLU
H2 2025 - Cell C restructuring and 11% revenue growth enabled dividend resumption and strong cash flow.BLU
H1 2026